Track topics on Twitter Track topics that are important to you
The data layer devices in the Software Defined Network (SDN) play an important role in packet forwarding. However, whether the forwarding task can be efficiently completed by the node has not attracted enough attention. A method called TrustBlock is proposed in this paper, which introduces trust as a security attribute in SDN routing planning. Besides, in order to enhance the integrity and controllability of trust evaluation, the double-layer blockchain architecture is established. In the first layer, the behavior data of the node is recorded, and then the trust calculation is performed in the second layer. In the evaluation model, nodes' trust is calculated from three aspects: direct trust, indirect trust and historical trust. Firstly, from the perspective of security, blockchain is used to achieve identity authentication of nodes, after that, from the perspective of reliability, the forwarding status is used to calculate the trust value. Secondly, consensus algorithm is used to filter malicious recommendation trust value and prevent colluding attacks. Finally, the adaptive historical trust weight is designed to prevent the periodic attack. In this paper, the entropy method is used to determine the weight of each evaluation attribute, which can avoid the problem that the subjective judgment method is not adaptable to the weight setting. Simulation results show that the detection rate of the TrustBlock is up to 98.89%, which means this model can effectively identify the abnormal nodes in SDN. Moreover, it is attractive in terms of integrity and controllability.
This article was published in the following journal.
Name: PloS one
Trust between developers influences the success of open source software (OSS) projects. Although existing research recognizes the importance of trust, there is a lack of an effective and scalable comp...
Safety and efficiency of human-AI collaboration often depend on how humans could appropriately calibrate their trust towards the AI agents. Over-trusting the autonomous system sometimes causes serious...
In recent years, Linear Non-Gaussian Acyclic Model (LiNGAM) has been widely used for the discovery of causal network. However, solutions based on LiNGAM usually yield high computational complexity as ...
Classification of high dimensional data suffers from curse of dimensionality and over-fitting. Neural tree is a powerful method which combines a local feature selection and recursive partitioning to s...
We propose three different methods to determine the optimal number of hidden nodes based on L₁ regularization for a multilayer perceptron network. The first two methods, respectively, use a set of m...
Oligometastatic patients with inoperable thoracic nodes metastases from any primary, except for hematologic malignancies, will undergo a risk adaptive scheme of stereotactic body radiation...
The Autism Adaptive Community-based Treatment to Improve Outcomes Using Navigators (ACTION) Network—a new interdisciplinary network of 6 institutions—will blend clinical effectiveness ...
This project will evaluate the neuro-cognitive outcomes of a novel, adaptive attention training in a healthy adolescent population.
Prior studies have shown that patient trust in their physician is associated with better health outcomes and lower levels of emotional distress. Patients who have low levels of trust in th...
The purpose of this study is to compare an adaptive Web-based learning system to a non-adaptive system for teaching physicians-in-training about ambulatory medicine.
Adaptive antiviral defense mechanisms, in archaea and bacteria, based on DNA repeat arrays called CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR elements) that function in conjunction with CRISPR-ASSOCIATED PROTEINS (Cas proteins). Several types have been distinguished, including Type I, Type II, and Type III, based on signature motifs of CRISPR-ASSOCIATED PROTEINS.
An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.
Works about clinical studies in which a prospectively planned opportunity is included to modify trial designs and hypotheses based on analysis of data from subjects in the study .
Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring.
Compounds based on reduced IMIDAZOLES containing a single double bond.